Success Stories: Our Efficient Response to the RFE Propelled a Postdoctoral Research Associate with 60 Citations in the Field of Molecular Biology to EB-1A Success
Client’s Testimonial:
“Congrats to your team too. This could never have been possible without your help and guidance. I am really happy for all what you did to make my case presentable and answer me back on each and every question in a very timely manner. I have experienced an unmatched professional service with best quality.”
On September 7th, 2016, we received another EB-1A (Alien of Extraordinary Ability) approval for a Postdoctoral Research Associate in the Field of Molecular Biology (Approval Notice).
General Field: Molecular Biology
Position at the Time of Case Filing: Postdoctoral Research Associate
Country of Origin: India
Service Center: Nebraska Service Center (NSC)
State of Residence at the Time of Filing: Missouri
Approval Notice Date: September 7th, 2016
Processing Time: 6 months, 15 days (Premium Processing Requested)
Case Summary:
North America Immigration Law Group (WeGreened.com) recently helped a postdoctoral research associate from India get his EB-1A (Alien of Extraordinary Ability) petition approved. Together, our legal team and support staff worked diligently to prove to the USCIS that our client’s presence in the United States is distinctly advantageous to the nation. For one, his investigations on the development and elucidation of biomarkers of pancreatic and kidney disease, as well as therapeutic targets for treatment of liver and kidney fibrosis have given American healthcare professionals the tools they need to better treat patients at earlier stages of disease development.
With 60 citations and 38 instances of peer review under his belt as well as 10 published articles to his name, our client met the requirements to file his I-140 petition under EB-1A. To strengthen his case, we incorporated other relevant information into his petition packet such as his doctoral degree, his CV, evidence of his employment at the time of filing, as well as seven recommendation letters. These letters were contributed by other influential molecular biologists, all of whom agreed to lend their support for our client’s EB-1A petition. From a senior scientist in Zurich to a professor in Melbourne, our client’s supporters were made up of researchers based all around the world. This in itself is evidence of the fact that our client’s work progresses the field as a whole and not just the work of researchers based in the US. According to one of his recommenders: “[Client’s] studies are vital to satisfying modern day health care needs around the globe regarding the detection and treatment of this ailment. His research in the development of biomarkers is both highly specialized and demanded. [Client] has achieved a level of accomplishment that is largely unmatched.” Besides supporting evidence such as those listed above, our client’s petition packet also listed the various reasons why his work is crucial to the US and how stopping his research in the country would be detrimental to the nation.
Despite our strong presentation of our client’s solid credentials, the USCIS issued a Request for Evidence (RFE). Less than two months after we received notification of the RFE, we submitted our response to the USCIS. Our convincing reply persuaded them to approve our client’s EB-1A petition, proving yet again that we will do what it takes to help our clients get one step closer to their green cards. We congratulate our client on this milestone and wish him the best as he adjusts his status for permanent residence.